BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36535908)

  • 1. Effect of postoperative radiotherapy for patients with differentiated thyroid cancer.
    Ryu H; Wu HG; Lee KE; Chung EJ; Ahn SH; Park YJ; Choi HS
    Clin Endocrinol (Oxf); 2023 Jun; 98(6):803-812. PubMed ID: 36535908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation?
    Adilbay D; Yuan A; Romesser PB; Wong RJ; Shah JP; Shaha AR; Tuttle MR; Patel S; Lee NY; Ganly I
    Ann Surg Oncol; 2022 Sep; 29(9):5582-5590. PubMed ID: 35583688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
    Watanabe K; Igarashi T; Uchiyama M; Ojiri H
    Ann Nucl Med; 2020 Dec; 34(12):920-925. PubMed ID: 32940889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years.
    Bal C; Satapathy S; Tupalli A; Ballal S
    Thyroid; 2022 Oct; 32(10):1220-1228. PubMed ID: 35983596
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer.
    Momesso DP; Vaisman F; Caminha LS; Pessoa CH; Corbo R; Vaisman M
    J Endocrinol Invest; 2014 Jan; 37(1):57-64. PubMed ID: 24464451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive iodine ablation post differentiated thyroid cancer surgery: an analysis of use and impact of the American Thyroid Association guidelines.
    Sia Y; Dave RV; Nour D; Miller JA; Skandarajah AR; Tasevski R
    ANZ J Surg; 2019 Nov; 89(11):E502-E506. PubMed ID: 31674140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
    Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
    Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.
    Wang LY; Ghossein R; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
    Thyroid; 2015 Sep; 25(9):993-8. PubMed ID: 26122000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
    Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease.
    Hirsch D; Gorshtein A; Robenshtok E; Masri-Iraqi H; Akirov A; Duskin Bitan H; Shimon I; Benbassat C
    J Clin Endocrinol Metab; 2018 Feb; 103(2):469-476. PubMed ID: 29126111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
    Schvartz C; Bonnetain F; Dabakuyo S; Gauthier M; Cueff A; Fieffé S; Pochart JM; Cochet I; Crevisy E; Dalac A; Papathanassiou D; Toubeau M
    J Clin Endocrinol Metab; 2012 May; 97(5):1526-35. PubMed ID: 22344193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.